In our study, we confirmed for the first time the promoter role of PHF12 in non-small cell lung cancer and proposed that PHF12-HDAC1 axis regulates the EGFR/AKT signaling pathway and promotes the development of lung cancer. This evidence concerns the gene EGFR and non-small cell lung carcinoma.